Literature DB >> 24880636

Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.

Douglas D Gunzler1, Adam Perzynski, Nathan Morris, Robert Bermel, Steven Lewis, Deborah Miller.   

Abstract

Screening for depression can be challenging in Multiple Sclerosis (MS) patients due to the overlap of depressive symptoms with other symptoms, such as fatigue, cognitive impairment and functional impairment, for MS patients. The aim of this study was to understand these overlapping symptoms and subsequently develop an adjusted depression screening tool for better clinical assessment of depressive symptoms in MS patients. We evaluated 3,507 MS patients with a self-reported depression screening (PHQ-9) score using a multiple indicator multiple cause modeling approach. Our models showed significant differential item functioning effects denoting significant overlap of depressive symptoms with all MS symptoms under study and good model fit. The magnitude of the overlap was especially large for fatigue. Adjusted depression screening scales were formed based on factor scores and loadings that will allow clinicians to understand the depressive symptoms separate from other symptoms for MS patients for improved patient care.

Entities:  

Mesh:

Year:  2014        PMID: 24880636      PMCID: PMC4824308          DOI: 10.1007/s10865-014-9574-5

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  29 in total

1.  A RATIONALE AND TEST FOR THE NUMBER OF FACTORS IN FACTOR ANALYSIS.

Authors:  J L HORN
Journal:  Psychometrika       Date:  1965-06       Impact factor: 2.500

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Psychometric evaluation of the Chicago Multiscale Depression Inventory in multiple sclerosis patients.

Authors:  C-H Chang; D L Nyenhuis; D Cella; T Luchetta; K Dineen; A T Reder
Journal:  Mult Scler       Date:  2003-03       Impact factor: 6.312

5.  Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes.

Authors:  B Muthén; L K Muthén
Journal:  Alcohol Clin Exp Res       Date:  2000-06       Impact factor: 3.455

6.  Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory?

Authors:  J E Aikens; M A Reinecke; N H Pliskin; J S Fischer; J S Wiebe; L M McCracken; J L Taylor
Journal:  J Behav Med       Date:  1999-04

Review 7.  The multiple sclerosis functional composite: a clinically meaningful measure of disability.

Authors:  Chris H Polman; Richard A Rudick
Journal:  Neurology       Date:  2010-04-27       Impact factor: 9.910

8.  Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.

Authors:  Kirsten Sjonnesen; Sandy Berzins; Kirsten M Fiest; Andrew G M Bulloch; Luanne M Metz; Brett D Thombs; Scott B Patten
Journal:  Postgrad Med       Date:  2012-09       Impact factor: 3.840

9.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis.

Authors:  R H B Benedict; I Fishman; M M McClellan; R Bakshi; B Weinstock-Guttman
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

10.  Validity of performance scales for disability assessment in multiple sclerosis.

Authors:  R A Marrie; M Goldman
Journal:  Mult Scler       Date:  2007-07-10       Impact factor: 6.312

View more
  10 in total

1.  A tutorial on structural equation modeling for analysis of overlapping symptoms in co-occurring conditions using MPlus.

Authors:  Douglas D Gunzler; Nathan Morris
Journal:  Stat Med       Date:  2015-06-04       Impact factor: 2.373

2.  Heterogeneous depression trajectories in multiple sclerosis patients.

Authors:  Douglas D Gunzler; Nathan Morris; Adam Perzynski; Daniel Ontaneda; Farren Briggs; Deborah Miller; Robert A Bermel
Journal:  Mult Scler Relat Disord       Date:  2016-08-05       Impact factor: 4.339

Review 3.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

4.  Smokers with MS have greater decrements in quality of life and disability than non-smokers.

Authors:  Farren Bs Briggs; Douglas D Gunzler; Daniel Ontaneda; Ruth Ann Marrie
Journal:  Mult Scler       Date:  2017-01-06       Impact factor: 6.312

5.  Effect of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey.

Authors:  Ann D Bass; Bart Van Wijmeersch; Lori Mayer; Mathias Mäurer; Aaron Boster; Matt Mandel; Colin Mitchell; Kersten Sharrock; Barry Singer
Journal:  Int J MS Care       Date:  2019-08-28

6.  Characterizing fatigue phenotypes with other symptoms and clinically relevant outcomes among people with multiple sclerosis.

Authors:  Matthew Plow; Douglas D Gunzler; Julia H C Chang
Journal:  Qual Life Res       Date:  2022-08-18       Impact factor: 3.440

7.  Fatigue and Comorbidities in Multiple Sclerosis.

Authors:  Kirsten M Fiest; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kyla A McKay; Lindsay I Berrigan; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Mar-Apr

8.  Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: A systematic review.

Authors:  Sarah Patrick; Peter Connick
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

9.  Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.

Authors:  Abdullah Al-Asmi; Salim Al-Rawahi; Zahir Saif Al-Moqbali; Yahya Al-Farsi; Musthafa M Essa; May El-Bouri; Roopa P Koshy; Arunodaya R Gujjar; P C Jacob; Abeer Al-Hodar; Samir Al Adawi
Journal:  BMC Neurol       Date:  2015-08-05       Impact factor: 2.474

10.  REFRESH protocol: a non-inferiority randomised clinical trial comparing internet and teleconference to in-person 'Managing Fatigue' interventions on the impact of fatigue among persons with multiple sclerosis.

Authors:  Matthew Plow; Tanya Packer; Virgil G Mathiowetz; Kathy Preissner; Setareh Ghahari; Abdus Sattar; Francois Bethoux; Marcia Finlayson
Journal:  BMJ Open       Date:  2020-08-16       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.